$TVRD
Tvardi Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.61
▼-0.57%-$0.009
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTvardi Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is TVRD down today? It is at $1.61 (-0.57%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TVRD spikes, and full due diligence on TVRD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TVRD 6 times in the last 30 days. Create a free account to track $TVRD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TVRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TVRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystTvardi Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tweardy Samuel David Beneficial Owner (10%) | Sold (automatic/other) | -631K 4.7% of company | sold 67% | 316K | n/a | Jul 7, 25 |
Wirk Shaheen Director | Acquired (grant/award) | +4K 0.03% of company | n/a | 4K | n/a | Apr 15, 25 |
Wirk Shaheen Director | Acquired (grant/award) | +439K 3.3% of company | n/a | 439K | n/a | Apr 15, 25 |
Hall Wallace L Jr Director | Acquired (grant/award) | +247K 1.8% of company | n/a | 247K | n/a | Apr 15, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TVRD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TVRD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TVRD last traded at $1.61, down 0.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Tvardi Therapeutics, Inc. Common Stock (TVRD) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TVRD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TVRD 6 times in the last 30 days.
TVRD (Tvardi Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $22M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TVRD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TVRD discussion
Sign in to ask a question or join the discussion.